Effects of Sleep Disorders on Hemoglobin A1c Levels in Type 2 Diabetic Patients

Basit Öğe Kaydı
dc.authoridSelçuk, Engin Burak/0000-0001-8484-0223
dc.authoridKeskin, Ahmet/0000-0001-8986-4742
dc.authoridYILDIZ, PINAR/0000-0002-3625-9829
dc.authoridBilgin, Muzaffer/0000-0002-6072-6466
dc.authorwosidSelçuk, Engin Burak/AAR-7556-2020
dc.authorwosidBilgin, Muzaffer/AAG-3041-2020
dc.authorwosidKeskin, Ahmet/ITT-0280-2023
dc.authorwosidYILDIZ, PINAR/HHC-1164-2022
dc.contributor.authorKeskin, Ahmet
dc.contributor.authorUnalacak, Murat
dc.contributor.authorBilge, Ugur
dc.contributor.authorYildiz, Pinar
dc.contributor.authorGuler, Seda
dc.contributor.authorSelcuk, Engin Burak
dc.contributor.authorBilgin, Muzaffer
dc.date.accessioned2024-08-04T20:41:22Z
dc.date.available2024-08-04T20:41:22Z
dc.date.issued2015
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground: Studies have reported the presence of sleep disorders in approximately 50-70% of diabetic patients, and these may contribute to poor glycemic control, diabetic neuropathy, and overnight hypoglycemia. The aim of this study was to determine the frequency of sleep disorders in diabetic patients, and to investigate possible relationships between scores of these sleep disorders and obstructive sleep apnea syndrome (OSAS) and diabetic parameters (fasting blood glucose, glycated hemoglobin A1c [HbA1c], and lipid levels). Methods: We used the Berlin questionnaire (BQ) for OSAS, the Epworth Sleepiness Scale (ESS), and the Pittsburgh Sleep Quality Index (PSQI) to determine the frequency of sleep disorders and their possible relationships with fasting blood glucose, HbA1c, and lipid levels. Results: The study included 585 type 2 diabetic patients admitted to family medicine clinics between October and December 2014. Sleep, sleep quality, and sleep scores were used as the dependent variables in the analysis. The ESS scores showed that 54.40% of patients experienced excessive daytime sleepiness, and according to the PSQI, 64.30% experienced poor-quality sleep. The BQ results indicated that 50.20% of patients were at high-risk of OSAS. HbAlc levels correlated significantly with the ESS and PSQI results (r = 0.23, P < 0.001 and r = 0.14, P = 0.001, respectively), and were significantly higher in those with high-risk of OSAS as defined by the BQ (P < 0.001). These results showed that HbAlc levels were related to sleep disorders. Conclusions: Sleep disorders are common in diabetic patients and negatively affect the control of diabetes. Conversely, poor diabetes control is an important factor disturbing sleep quality. Addressing sleep disturbances in patients who have difficulty controlling their blood glucose has dual benefits: Preventing diabetic complications caused by sleep disturbance and improving diabetes control.en_US
dc.identifier.doi10.4103/0366-6999.171415
dc.identifier.endpage3297en_US
dc.identifier.issn0366-6999
dc.identifier.issue24en_US
dc.identifier.pmid26668142en_US
dc.identifier.scopus2-s2.0-84949741106en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage3292en_US
dc.identifier.urihttps://doi.org/10.4103/0366-6999.171415
dc.identifier.urihttps://hdl.handle.net/11616/97084
dc.identifier.volume128en_US
dc.identifier.wosWOS:000367398400005en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofChinese Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHemoglobin A1cen_US
dc.subjectObstructive Sleep Apnea Syndromeen_US
dc.subjectSleep Disordersen_US
dc.subjectType 2 Diabetes Mellitusen_US
dc.titleEffects of Sleep Disorders on Hemoglobin A1c Levels in Type 2 Diabetic Patientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu